Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Elite Pharmaceuticals ( (ELTP) ) is now available.
Elite Pharmaceuticals has launched a generic version of Norco®, a prominent pain management drug, potentially tapping into a lucrative market with reported annual sales of $300 million. This move underscores Elite’s strategy to focus on niche generic products, leveraging its specialized manufacturing facilities in New Jersey to produce both immediate and controlled-release oral dose medications.
For a thorough assessment of ELTP stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- Intel Stock (NASDAQ:INTC) Slips Despite Growing Interest in AI
- “…Tied to the Effort From the Administration” Boeing Stock (NYSE:BA) Blasts Up as Boeing Counts on New Top Sales Rep in China: President Trump
- “We Do Not Have Conflicting Interests….” Microsoft Stock (NASDAQ:MSFT) Gains on New Plan to be the Agentic AI Internet’s Backbone